Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
Sign Up to like & getrecommendations! Published in 2019 at "Seminars in arthritis and rheumatism"
DOI: 10.1016/j.semarthrit.2019.01.003
Abstract: OBJECTIVE Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in unselected patients with GCA in clinical… read more here.
Keywords: giant cell; observational open; clinical practice; tcz ... See more keywords